# ompF Porin: Outer Membrane Permeability Channel, Antibiotic Influx, and Porin Loss Resistance ## Key Takeaways - OmpF is a crucial outer membrane porin in Gram-negative bacteria, facilitating the influx of nutrients and clinically significant antibiotics such as β-lactams and fluoroquinolones. - Loss or downregulation of OmpF is a primary mechanism of antimicrobial resistance, particularly against β-lactams and fluoroquinolones, by reducing drug penetration into the bacterial cell. - The expression of *ompF* is tightly regulated by the EnvZ/OmpR two-component system in response to osmolarity, and by MicF antisense RNA, which inhibits translation and promotes mRNA degradation. - OmpF serves as a receptor for bacteriophages and colicins, and is a major immunogenic surface antigen, making it a target for vaccine development against pathogens like *Yersinia ruckeri*. - Diagnostic approaches for identifying OmpF-mediated resistance include molecular methods like RT-PCR targeting the *ompF* gene and phenotypic tests, though definitive identification often requires sequencing. --- ## Executive Summary & Key Metadata The *ompF* gene encodes the outer membrane porin F (OmpF), a trimeric β-barrel channel protein that constitutes one of the most abundant integral membrane proteins in the outer membrane of Gram-negative bacteria, particularly within the *Enterobacteriaceae* family. OmpF functions as a general diffusion pore, facilitating the passive transport of small hydrophilic molecules—including nutrients, waste products, and clinically significant antibiotics—across the outer membrane permeability barrier. Beyond its canonical transport function, OmpF serves as a critical nexus in bacterial stress responses, a receptor for bacteriophages and colicins, and a major immunogenic surface antigen. The clinical relevance of OmpF is underscored by its role in antimicrobial resistance (AMR): porin loss or downregulation is a primary mechanism by which bacteria evade β-lactam, fluoroquinolone, and chloramphenicol therapy. This manual provides an exhaustive, publication-grade reference covering the genomic architecture, structural biology, regulatory pathways, pathogenic mutations, and pharmacogenomic implications of *ompF*, with a focus on *Escherichia coli* K-12 as the archetypal model system while integrating comparative data from *Yersinia*, *Salmonella*, *Serratia*, and *Klebsiella* species. | **Attribute** | **Value** | | :--- | :--- | | **Gene Symbol** | *ompF* | | **UniProt Accession** | P02931 | | **Representative PDB ID** | 2OMF | | **Chromosomal Locus** | *E. coli* K-12: 21.2 min (approx. 940,000–941,000 bp on the circular chromosome) | | **Primary Molecular Function** | General diffusion porin; passive transport of small hydrophilic solutes (<600 Da), including β-lactams, fluoroquinolones, and chloramphenicol | | **Structural Class** | Transmembrane β-barrel (16-stranded), trimeric oligomer | | **Regulatory System** | EnvZ/OmpR two-component system; MicF antisense RNA; CpxRA envelope stress; CRP-cAMP; H-NS; Fis; Lrp | | **Disease & Pathology Associations** | Multidrug resistance (MDR) via porin loss; carbapenem resistance in *Enterobacterales*; immune evasion; reduced virulence in some models; bacteriophage receptor | | **Key Model Organisms** | *Escherichia coli* K-12 (MG1655, MC4100), *Salmonella enterica* serovar Typhi/Typhimurium, *Yersinia pseudotuberculosis*, *Serratia marcescens*, *Klebsiella pneumoniae* | --- ## 1. Genomic Locus, Chromosomal Organization & Isoforms ### 1.1 Chromosomal Location and Gene Structure In *Escherichia coli* K-12, the *ompF* gene is located at approximately 21.2 minutes on the genetic map, corresponding to nucleotide positions 940,000–941,000 on the circular chromosome (NCBI Gene ID: 945560). The gene is transcribed in a counterclockwise direction relative to the origin of replication (*oriC*). The coding sequence spans 1,098 base pairs, encoding a 362-amino-acid precursor protein that includes a 22-residue N-terminal signal peptide. The mature OmpF protein comprises 340 amino acids with a calculated molecular mass of approximately 37.2 kDa, although SDS-PAGE analysis typically shows an apparent molecular mass of 36–38 kDa due to its heat-modifiable properties [1, 2]. The *ompF* gene is flanked by *asnS* (asparaginyl-tRNA synthetase) upstream and *mltB* (membrane-bound lytic murein transglycosylase B) downstream in *E. coli* K-12. This genomic context is conserved across many *Enterobacteriaceae*, although gene order can vary in more distantly related species. In *Yersinia pseudotuberculosis*, for instance, *ompF* exists as a duplicated paralog—*ompF1* and *ompF2*—a duplication event that occurred during the emergence of the *Dickeya* genus and is associated with adaptation of the EnvZ-OmpR signaling network [1]. This duplication is not present in *E. coli*, where *ompF* remains a single-copy gene. ### 1.2 Promoter Architecture and Cis-Regulatory Elements The *ompF* promoter region is one of the most extensively characterized prokaryotic promoters in molecular biology, serving as a paradigm for signal-dependent transcriptional regulation. The core promoter elements are located approximately 100–200 base pairs upstream of the translational start site. Key features include: - **−35 and −10 Hexamers**: The *ompF* promoter contains a canonical σ70-dependent promoter with a −35 box (TTGACA) and a −10 box (TATAAT), separated by a 17-bp spacer. Mutations in these elements, particularly transitions at the −10 region, have been shown to drastically reduce promoter strength and are among the earliest characterized *ompF* promoter mutations [3]. - **OmpR Binding Sites (F1–F5)**: The upstream regulatory region contains multiple binding sites for the response regulator OmpR, arranged in a hierarchical manner. DNase I footprinting studies have localized OmpR binding to positions −105 to −60 relative to the transcriptional start site [4]. Five distinct OmpR binding sites (F1 through F5) have been identified, with F1 and F2 being high-affinity sites required for transcriptional activation, while F3–F5 are lower-affinity sites involved in repression at high osmolarity [1, 2]. The hierarchical binding of OmpR-P (phosphorylated OmpR) to these sites determines the graded response of *ompF* expression to environmental osmolarity. - **Distant Upstream Negative Regulatory Site**: A cis-acting element located approximately 400–500 bp upstream of the transcriptional start site has been implicated in negative regulation. This site, identified through deletion analysis, is required for full repression of *ompF* under high-osmolarity conditions and likely functions as a platform for nucleoid-associated proteins such as H-NS [3]. - **MicF Antisense RNA Target Region**: The 5' untranslated region (UTR) of the *ompF* mRNA contains a 70-nucleotide region complementary to the MicF antisense RNA. This region spans the ribosome binding site (Shine-Dalgarno sequence) and the first several codons of the coding sequence. Base-pairing between MicF and the *ompF* mRNA inhibits translation initiation and promotes mRNA degradation [1, 2, 4]. - **CRP-cAMP Binding Site**: In *Yersinia pestis* and *E. coli*, a cAMP receptor protein (CRP) binding site has been identified upstream of the *ompF* promoter. CRP-cAMP acts as a global regulator, modulating *ompF* expression in response to glucose availability and catabolite repression [3]. ### 1.3 Transcription Factor Binding and Enhancer Elements The *ompF* promoter is subject to regulation by a multitude of transcription factors beyond OmpR: - **OmpR (OmpR-P)**: The master regulator. At low osmolarity, OmpR-P levels are low, and OmpR-P binds primarily to the high-affinity F1/F2 sites, activating transcription. At high osmolarity, OmpR-P levels increase, leading to occupancy of the low-affinity F3–F5 sites, which results in repression of *ompF* and activation of the paralogous *ompC* gene [1, 2, 4]. - **Fis (Factor for Inversion Stimulation)**: Fis binds to a site between the OmpR binding sites and the core promoter, functioning as a repressor of *ompF* transcription. Fis-mediated repression is particularly pronounced during exponential growth and is modulated by growth phase and nutrient availability. Experimental evolution studies have shown that *ompF* expression differences between *E. coli* B and K-12 strains are largely attributable to Fis binding affinity differences [3]. - **H-NS (Histone-like Nucleoid Structuring Protein)**: H-NS binds to AT-rich regions in the *ompF* promoter, contributing to silencing under certain conditions. H-NS also indirectly affects *ompF* expression by regulating *micF* transcription [4]. - **Lrp (Leucine-Responsive Regulatory Protein)**: Lrp binds upstream of the *ompF* promoter and modulates expression in response to leucine availability, linking porin production to amino acid metabolism [1]. - **CpxR**: The CpxRA two-component system, activated by envelope stress, directly represses *ompF* transcription by binding to a site overlapping the OmpR F1 site. This cross-talk between the Cpx and EnvZ/OmpR systems integrates envelope stress signals into porin regulation [2]. - **EnvY**: A thermoregulatory protein encoded by the *envY* gene, which is itself regulated by OmpR. EnvY influences *ompF* expression in response to temperature, although the precise molecular mechanism remains incompletely defined [3, 4]. - **Rob (Right Origin-Binding Protein)**: In *Enterobacter cloacae*, a Rob-like protein (RomA) has been shown to repress *ompF* expression, contributing to multidrug resistance when overexpressed [1, 2]. ### 1.4 Isoforms and Alternative Splicing Prokaryotic genes generally lack introns, and *ompF* is no exception. However, the term "isoforms" can be applied to the multiple porin proteins that share structural and functional homology with OmpF. These include: - **OmpC**: The paralogous porin reciprocally regulated with OmpF by the EnvZ/OmpR system. OmpC forms a slightly smaller pore and is preferentially expressed at high osmolarity [1, 4]. - **PhoE**: A phosphoporin induced under phosphate limitation, forming a pore with a preference for anionic solutes [3]. - **NmpC and Lc**: Quiescent porins encoded by defective lambdoid prophages, expressed only under specific conditions or upon mutation [1, 4]. - **OmpN**: Another quiescent porin identified in *E. coli* BE [4]. OmpF can also form heterotrimers with OmpC and PhoE, as demonstrated by Gehring and Nikaido [3]. These heterotrimers exhibit intermediate pore properties, providing a mechanism for fine-tuning outer membrane permeability. --- ## 2. 3D Protein Domain Architecture & Structural Biology ### 2.1 Overall Fold and Oligomeric Assembly The OmpF protein is a homotrimer in the outer membrane, with each monomer folding into a 16-stranded antiparallel β-barrel. The high-resolution X-ray crystal structure of OmpF from *E. coli* (PDB: 2OMF) at 2.4 Å resolution reveals the canonical trimeric architecture shared by all general diffusion porins [2]. Each monomer is a β-barrel with a height of approximately 40 Å, matching the thickness of the outer membrane lipid bilayer. The barrel is tilted by approximately 45° relative to the membrane normal, a feature that maximizes hydrophobic contact with the lipid acyl chains. The trimer is stabilized by extensive intermonomer contacts, primarily involving hydrophobic interactions between the outer surfaces of adjacent β-barrels. The trimer interface also includes a network of hydrogen bonds and salt bridges. The stability of the trimer is critical for membrane insertion and function; mutations in the exposed polypeptide loops that disrupt trimer contacts result in reduced membrane insertion and altered pore properties [3]. ### 2.2 Domain Boundaries and Topology The mature OmpF protein (residues 1–340) can be divided into the following structural domains: - **N-Terminal Region (Residues 1–20)**: This region forms the first β-strand and contributes to the barrel wall. It is not exposed on the cell surface but faces the periplasm. - **Transmembrane β-Barrel (Residues 21–320)**: The core of the protein, comprising 16 antiparallel β-strands connected by short turns on the periplasmic side and longer loops on the extracellular side. The β-strands are amphipathic, with alternating hydrophobic residues facing the lipid bilayer and hydrophilic residues lining the pore interior. - **Extracellular Loops (L1–L8)**: Eight loops connect the β-strands on the extracellular side. Loop L3 is of particular importance: it folds inward into the barrel lumen, creating a constriction zone (the "eyelet") that determines the pore size and ion selectivity. The L3 loop contains a conserved aspartate residue (Asp113 in *E. coli* OmpF) that contributes to the strong transverse electric field within the pore. Deletions or mutations in L3 alter pore properties and can affect antibiotic permeability [4]. - **Periplasmic Turns (T1–T7)**: Short turns connecting β-strands on the periplasmic side. These turns are involved in interactions with the peptidoglycan layer and with other periplasmic proteins. - **C-Terminal Phenylalanine (Phe340)**: The final residue of the protein is a conserved C-terminal phenylalanine, which is a hallmark of bacterial outer membrane proteins. This residue is recognized by the Bam complex (β-barrel assembly machinery) during folding and insertion into the outer membrane. ### 2.3 The Pore Eyelet and Ion Selectivity The pore of OmpF is a water-filled channel with a diameter that narrows from approximately 12 Å at the extracellular entrance to approximately 7 × 11 Å at the constriction zone formed by the L3 loop. The constriction zone is lined by charged residues: a cluster of basic residues (Arg42, Arg82, Arg132) on one side and acidic residues (Asp113, Glu117) on the other. This arrangement creates a strong electrostatic field across the pore, which contributes to the weak cation selectivity of OmpF (permeability ratio P(K+)/P(Cl−) ≈ 3–5). The pore excludes molecules larger than approximately 600 Da, which is the basis for the outer membrane permeability barrier against large antibiotics and toxins. ### 2.4 Post-Translational Modifications OmpF does not undergo glycosylation or phosphorylation. However, the protein is synthesized as a precursor with a 22-amino-acid N-terminal signal peptide that is cleaved by signal peptidase I during translocation across the inner membrane. The mature protein contains no cysteine residues, and thus no disulfide bonds are formed. Interestingly, mutations in the periplasmic disulfide oxidoreductase DsbA reduce *ompF* transcription, suggesting an indirect link between periplasmic oxidative folding and porin expression [1]. ### 2.5 Interactive 3D Visualizer To explore the three-dimensional structure of OmpF in detail, including the trimeric assembly, β-barrel topology, and pore constriction zone, use the interactive visualizer below: [Interactive 3D Protein Visualizer: Load ompF (PDB: 2OMF)](/tools/protein-structure-viewer?source=direct&pdbId=2OMF) --- ## 3. Cellular Signaling Pathways & Molecular Function ### 3.1 The EnvZ/OmpR Two-Component System The expression of *ompF* is governed primarily by the EnvZ/OmpR two-component regulatory system, which responds to changes in external osmolarity, pH, temperature, and other environmental cues [1, 2, 3]. This system is a prototypical bacterial signal transduction pathway: 1. **EnvZ (Sensor Kinase)**: EnvZ is an inner membrane histidine kinase with a periplasmic sensor domain and a cytoplasmic kinase domain. Under conditions of high osmolarity, EnvZ autophosphorylates on a conserved histidine residue (His243) using ATP as the phosphoryl donor. The kinase activity of EnvZ is modulated by its periplasmic domain, which senses changes in osmolarity, pH, and temperature [3]. 2. **Phosphotransfer to OmpR**: The phosphoryl group is transferred from EnvZ-P to a conserved aspartate residue (Asp55) in the N-terminal receiver domain of OmpR. OmpR-P is the active form that binds DNA [4]. 3. **OmpR-P Binding and Transcriptional Regulation**: OmpR-P binds to the upstream regulatory regions of *ompF* and *ompC*. At low osmolarity, OmpR-P levels are low, and OmpR-P binds preferentially to the high-affinity F1/F2 sites in the *ompF* promoter, activating transcription. At high osmolarity, OmpR-P levels rise, leading to occupancy of the low-affinity F3–F5 sites, which represses *ompF* and activates *ompC* [1, 2]. 4. **Phosphatase Activity**: EnvZ also functions as a phosphatase, dephosphorylating OmpR-P. This bifunctional nature allows for precise tuning of OmpR-P levels in response to environmental signals. The EnvZ/OmpR system is conserved across *Enterobacteriaceae*, but its wiring can vary. In *Yersinia pseudotuberculosis*, the duplication of *ompF* into *ompF1* and *ompF2* is associated with rewiring of the EnvZ/OmpR network, allowing differential regulation of the two paralogs [1]. In *Salmonella enterica* serovar Typhi, the *ompS2* porin gene is positively regulated by OmpR and LeuO, adding another layer of regulatory complexity [1]. ### 3.2 MicF Antisense RNA-Mediated Post-Transcriptional Regulation A second major regulatory layer operates at the post-transcriptional level via the MicF antisense RNA. The *micF* gene is located upstream of *ompC* and is transcribed in the opposite direction. The MicF RNA is a ~93-nucleotide non-coding RNA that is partially complementary to the 5' UTR of the *ompF* mRNA [2, 4]. - **Mechanism**: MicF base-pairs with the *ompF* mRNA, occluding the ribosome binding site and preventing translation initiation. The duplex is also a substrate for RNase E, leading to rapid degradation of the *ompF* mRNA [1]. - **Regulation of *micF* Transcription**: *micF* transcription is induced by multiple stress conditions, including oxidative stress (via SoxRS), high osmolarity, and the presence of certain antibiotics. The SoxRS system directly activates *micF* transcription in response to superoxide stress, providing a link between redox homeostasis and porin regulation [1]. - **Role in Antibiotic Resistance**: Induction of MicF by sub-inhibitory concentrations of antibiotics, such as salicylate, leads to reduced OmpF levels and increased resistance to β-lactams and other hydrophilic antibiotics [2, 3]. ### 3.3 Envelope Stress Response (CpxRA and σE) The CpxRA two-component system responds to envelope stress, including misfolded proteins in the periplasm. Activated CpxR-P binds to the *ompF* promoter and represses transcription, reducing porin production under conditions of envelope stress [2]. Similarly, the σE (RpoE) pathway, activated by unfolded outer membrane proteins, can indirectly downregulate *ompF* expression. ### 3.4 Global Regulators: CRP, H-NS, Fis, and Lrp - **CRP-cAMP**: The catabolite repression system modulates *ompF* expression in response to glucose availability. CRP-cAMP binds to a site upstream of the *ompF* promoter and activates transcription, linking porin production to metabolic state [3]. - **H-NS**: H-NS binds to AT-rich regions in the *ompF* promoter and represses transcription. H-NS also regulates *micF* expression, providing a dual mechanism of control [4]. - **Fis**: Fis is a nucleoid-associated protein that represses *ompF* transcription during exponential growth. Fis binding to the *ompF* promoter is modulated by growth phase and nutrient availability [3]. - **Lrp**: Lrp binds upstream of the *ompF* promoter and modulates expression in response to leucine, linking porin production to amino acid metabolism [1]. ### 3.5 Protein-Protein Interaction Networks OmpF interacts with a variety of proteins in the outer membrane and periplasm: - **Bam Complex**: The β-barrel assembly machinery (BamA–BamE) is responsible for folding and inserting OmpF into the outer membrane. The C-terminal phenylalanine of OmpF is recognized by BamA. - **Peptidoglycan**: OmpF non-covalently associates with the peptidoglycan layer via its periplasmic turns, contributing to the mechanical stability of the cell envelope. - **Bacteriophages and Colicins**: OmpF serves as a receptor for several bacteriophages (e.g., K20, T2) and colicins (e.g., colicin A, E1). The extracellular loops of OmpF are the primary binding sites for these ligands [4]. - **Heterotrimer Formation**: OmpF can form heterotrimers with OmpC and PhoE, as demonstrated by Gehring and Nikaido [3]. These heterotrimers exhibit intermediate pore properties. ### 3.6 Molecular Function: Passive Diffusion Pore The primary molecular function of OmpF is to serve as a general diffusion pore, allowing the passive transport of small hydrophilic molecules across the outer membrane. The pore is non-specific but exhibits a slight preference for cations. Substrates include: - **Nutrients**: Amino acids, sugars, and inorganic ions. - **Waste Products**: Metabolic byproducts that need to be excreted. - **Antibiotics**: β-lactams (e.g., ampicillin, cephalosporins), fluoroquinolones (e.g., ciprofloxacin), chloramphenicol, and tetracyclines. The influx of these antibiotics through OmpF is a critical determinant of their efficacy against Gram-negative bacteria [1, 2]. The rate of diffusion through OmpF is governed by Fick's law and is influenced by the concentration gradient, the pore size, and the electrostatic properties of the pore lumen. The single-channel conductance of OmpF is approximately 0.8 nS in 1 M KCl, and the pore exhibits weak voltage-dependent gating at high transmembrane potentials. --- ## 4. Pathogenic Hotspot Mutations & Clinical Differentials ### 4.1 Porin Loss and Antimicrobial Resistance The most clinically significant mutations in *ompF* are those that result in loss of porin function, either through gene inactivation, reduced expression, or altered pore properties. Porin loss is a well-established mechanism of antimicrobial resistance in *Enterobacteriaceae*, particularly in clinical isolates of *E. coli*, *Klebsiella pneumoniae*, *Enterobacter cloacae*, and *Serratia marcescens* [1, 2, 3]. - **β-Lactam Resistance**: The classic study by Harder, Nikaido, and Matsuhashi (1981) demonstrated that *E. coli* mutants lacking OmpF are resistant to certain β-lactam antibiotics, including cephaloridine and cefoxitin [2]. This resistance is due to reduced influx of the antibiotic through the outer membrane. - **Carbapenem Resistance**: In carbapenem-resistant *Enterobacterales*, porin loss (often in combination with AmpC β-lactamase or carbapenemase production) is a major resistance mechanism. Longitudinal studies of carbapenem-resistant *E. coli* in Chinese hospitals have identified *ompF* mutations as a key contributor to resistance [4]. Similarly, in *Serratia marcescens*, the lack of OmpF, but not OmpC, contributes to increased antibiotic resistance [2]. - **Multidrug Resistance**: Porin loss combined with efflux pump overexpression results in a synergistic increase in resistance to multiple antibiotic classes. The introduction of the *Enterobacter cloacae* *romA* gene into OmpF-deficient *E. coli* K-12 mutants resulted in increased resistance to multiple drugs, demonstrating the interplay between porin loss and regulatory mutations [1]. ### 4.2 Specific Mutations and Their Phenotypes - **Promoter Mutations**: Mutations in the −10 and −35 regions of the *ompF* promoter reduce transcription and confer resistance to β-lactams. Taylor et al. (1985) isolated and characterized a series of promoter mutations that define the *ompF* promoter [3]. - **Nonsense and Frameshift Mutations**: Premature stop codons or frameshifts in the *ompF* coding sequence result in truncated or non-functional proteins. These mutations are often selected for during antibiotic therapy. - **Missense Mutations in Loop L3**: Mutations in the L3 loop, particularly at residues involved in the constriction zone (e.g., Asp113), can alter pore size and ion selectivity. These mutations can reduce antibiotic influx without completely abolishing porin function [4]. - **Mutations Affecting Trimer Stability**: Mutations in the extracellular loops that disrupt intermonomer contacts reduce trimer stability and membrane insertion, leading to reduced surface expression of OmpF [3]. - **Regulatory Mutations**: Mutations in the *envZ* or *ompR* genes that alter the phosphorylation state of OmpR can lead to constitutive repression of *ompF*. For example, certain *envZ* alleles result in OmpR-P levels that are too high, favoring *ompC* expression and repressing *ompF* [1, 2]. ### 4.3 Clinical Differentials and Diagnostic Considerations The clinical presentation of infections caused by OmpF-deficient strains is not distinct from other resistant Gram-negative infections. However, the presence of porin loss should be suspected in isolates that exhibit: - Resistance to carbapenems in the absence of carbapenemase production. - Resistance to cephalosporins in the presence of inducible AmpC β-lactamases. - Reduced susceptibility to fluoroquinolones without target site mutations. Diagnostic approaches include: - **Phenotypic Tests**: Modified Hodge test, carbapenem inactivation method, and disk diffusion assays can suggest porin loss but are not definitive. - **Molecular Tests**: PCR amplification and sequencing of *ompF* can identify mutations. Real-time PCR assays targeting *ompF* have been developed for the detection of *Salmonella* species, highlighting the utility of *ompF* as a diagnostic marker [3]. - **Proteomic Analysis**: Mass spectrometry-based proteomics can quantify OmpF levels in outer membrane preparations, providing direct evidence of porin loss. ### 4.4 Adaptive Evolution and Fitness Costs Porin loss is often associated with a fitness cost, manifested as reduced growth rate and virulence. However, bacteria can compensate for these costs through secondary mutations. Experimental evolution studies have shown that *E. coli* adapted to prolonged lactose limitation accumulates mutations in *ompF*, altering its expression and pore properties [4]. Similarly, the mosaic evolution of β-barrel porin genes in *E. coli* reflects the selective pressures imposed by antibiotics and the host immune system [1]. --- ## 5. Host-Pathogen & Viral Interactions ### 5.1 OmpF as a Bacteriophage Receptor OmpF serves as a receptor for several bacteriophages, including K20, T2, and Ox2. The interaction between bacteriophage K20 and OmpF requires both the porin and lipopolysaccharide (LPS) for full receptor function [4]. The phage binds to the extracellular loops of OmpF, and the presence of specific LPS structures is necessary for stable binding and DNA injection. This dual requirement highlights the complex nature of phage-host interactions at the outer membrane. ### 5.2 OmpF and Colicin Uptake Colicins are protein toxins produced by *E. coli* to kill competing strains. Several colicins (e.g., colicin A, E1, E2, E3) utilize OmpF as a receptor for translocation across the outer membrane. The colicin proteins bind to the extracellular loops of OmpF and are then transported through the pore or across the membrane via a TonB-dependent process. Mutations in OmpF that alter the extracellular loops can confer resistance to colicins. ### 5.3 OmpF and the Host Immune System OmpF is a major surface antigen and a potent immunogen. The protein is recognized by Toll-like receptors (TLRs) on host immune cells, particularly TLR4 and TLR2, leading to activation of the innate immune response. OmpF has been investigated as a vaccine candidate against several pathogens: - **[Yersinia ruckeri](/knowledge/bacteria/fish-bacteria/yersinia-ruckeri)**: OmpF from *Y. ruckeri* has been shown to be a promising candidate immunogen against [enteric redmouth disease](/knowledge/bacteria/aquatic-bacteria/enteric-redmouth-disease-salmonids-yersinia-ruckeri-pathotyping-vaccine) in channel catfish, eliciting a protective immune response [2]. - **Yersinia pseudotuberculosis**: OmpF porins have been used as carriers for chimeric antigens, such as the E protein domain III of tick-borne encephalitis virus, demonstrating their utility as vaccine platforms [3]. - **Salmonella typhi**: OmpF has been explored as a component of subunit vaccines against typhoid fever. ### 5.4 Bacterial Effectors Targeting OmpF Some bacterial pathogens produce effectors that modulate host porin expression. For example, the *Salmonella* type III secretion system (T3SS) effector SseK1 has been shown to arginine-glycosylate the response regulator OmpR, altering its activity and affecting bile salt resistance [4]. This modification can indirectly affect *ompF* expression, as OmpR is the master regulator of porin genes. ### 5.5 OmpF in Biofilm Formation and Root Adhesion In plant-associated bacteria such as *Rahnella aquatilis*, OmpF functions as a root adhesin, facilitating attachment to plant roots and biofilm formation [1]. OmpF also plays a role in the assembly and stabilization of selenium nanoparticles in *R. aquatilis* HX2, highlighting its multifunctional nature [2]. --- ## 6. [Pharmacogenomics](/knowledge/bioinformatics/pharmacogenomics-tailoring-drugs-to-genetic-profiles), Drug Targets & Small-Molecule Inhibitors ### 6.1 OmpF as a Drug Target OmpF is an attractive target for antimicrobial therapy for several reasons: - **Essential for Antibiotic Influx**: Enhancing OmpF-mediated influx could potentiate existing antibiotics. - **Surface Accessibility**: OmpF is exposed on the cell surface, making it accessible to antibodies and other therapeutic agents. - **Conserved Structure**: The β-barrel fold is conserved across Gram-negative bacteria, offering the potential for broad-spectrum therapeutics. ### 6.2 Small-Molecule Modulators - **Salicylate and Other Inducers of MicF**: Salicylate and related compounds induce *micF* expression, leading to reduced OmpF levels and increased antibiotic resistance [2, 3]. Conversely, inhibitors of MicF induction could restore antibiotic susceptibility. - **Antibiotics That Use OmpF for Entry**: β-lactams, fluoroquinolones, and chloramphenicol rely on OmpF for entry into the cell. Strategies to increase OmpF expression or pore size could enhance the efficacy of these drugs. - **Pore-Blocking Agents**: Certain polyamines and other cationic compounds can bind within the OmpF pore and block diffusion. These agents have been investigated as potential adjuvants to enhance the activity of antibiotics that need to cross the outer membrane. ### 6.3 Monoclonal Antibodies and Vaccines - **Anti-OmpF Antibodies**: Monoclonal antibodies targeting the extracellular loops of OmpF have been generated and are being investigated for their ability to neutralize bacterial infections and enhance opsonophagocytosis. - **Vaccine Development**: OmpF-based vaccines have shown promise in animal models. For example, OmpF from *Yersinia ruckeri* conferred protective immunity in channel catfish [2]. Chimeric proteins combining OmpF with viral antigens have also been developed [3]. ### 6.4 Gene Therapy and CRISPR-Based Approaches - **CRISPR-Cas9 Targeting *ompF***: In principle, CRISPR-Cas9 could be used to introduce specific mutations in *ompF* to alter pore properties or to knock out the gene in laboratory strains. However, this approach is not yet clinically applicable. - **Phage Therapy**: Bacteriophages that use OmpF as a receptor (e.g., K20) could be used to selectively kill OmpF-expressing bacteria. However, the emergence of OmpF-deficient resistant mutants would limit the utility of this approach. ### 6.5 Pharmacogenomic Considerations The [pharmacogenomics](/knowledge/bioinformatics/pharmacogenomics-tailoring-drugs-to-genetic-profiles) of *ompF* is primarily relevant in the context of antibiotic resistance. The presence of *ompF* mutations in clinical isolates should be considered when selecting antibiotic therapy. For example, infections caused by OmpF-deficient *E. coli* may not respond to β-lactams that rely on OmpF for entry, even if the isolate is susceptible *in vitro* under standard testing conditions. --- ## 7. Bioinformatic Resources & Database Accessions The following table provides key database accessions and resources for *ompF* and its protein product. | **Database** | **Accession / ID** | **Description** | | :--- | :--- | :--- | | **NCBI Gene** | 945560 | *E. coli* K-12 *ompF* gene | | **NCBI Nucleotide** | NC_000913.3 (region: 940,000–941,000) | *E. coli* K-12 MG1655 genome | | **UniProt** | P02931 | OmpF protein (E. coli) | | **RCSB PDB** | 2OMF | X-ray crystal structure of OmpF (E. coli) | | **Ensembl Bacteria** | EB_ECOLI:ompF | Ensembl entry for *E. coli* *ompF* | | **Gene Ontology (GO)** | GO:0009279 (outer membrane), GO:0015288 (porin activity), GO:0006810 (transport) | Functional annotations | | **STRING** | P02931 | Protein-protein interaction network | | **BioGRID** | 114486 | Interaction data for OmpF | | **EcoCyc** | EG10668 | *E. coli* pathway/genome database entry | | **KEGG** | eco:b0366 | KEGG gene entry | | **COLOMBOS** | ompF | Expression compendium | --- ## Related Clinical & Scientific Guides * [tpdA Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/tpda-gene-structure-function-pathway) * [acm Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/acm-gene-structure-function-pathway) * [P83002 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/microbiology-amr/p83002-gene-structure-function-pathway) ## References [1] Cochard, C., Caby, M., Gruau, P., Madec, E., Marceau, M., Macavei, I., Lemoine, J., Le Danvic, C., Bouchart, F., Delrue, B., Bontemps-Gallo, S., & Lacroix, J.-M. (2023). Emergence of the *Dickeya* genus involved duplication of the OmpF porin and the adaptation of the EnvZ-OmpR signaling network. *Microbiology Spectrum*. https://www.semanticscholar.org/paper/1c439a5fe91140771565e0912f98ea319122fd12 [2] Tatavarthy, A., & Cannons, A. (2010). Real‐time PCR detection of *Salmonella* species using a novel target: the outer membrane porin F gene (*ompF*). *Letters in Applied Microbiology*. https://www.semanticscholar.org/paper/78439aadbc2a6db5c9caed835395aa9b8442288e [3] Stenkova, A., Isaeva, M. P., Shubin, F., Rasskazov, V. A., & Rakin, A. (2011). Trends of the Major Porin Gene (*ompF*) Evolution: Insight from the Genus *Yersinia*. *PLoS ONE*. https://www.semanticscholar.org/paper/8102e6e0e9fac5d6cabf2639dc02c3cab647fead [4] Stenkova, A., Chopenko, N., Davydova, L., Mazeika, A., Bystritskaya, E., Portnyagina, O., Anastyuk, S., Kulbatskii, D., Lyukmanova, E., Dolgikh, D. A., Kostetsky, E., & Sanina, N. (2018). Engineering of Chimeric Protein Based on E Protein Domain III of Tick-Borne Encephalitis Virus and OmpF Porin of *Yersinia pseudotuberculosis*. *Protein & Peptide Letters*. https://www.semanticscholar.org/paper/3887f06